chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge summary: "Brief Summary of Hospital Stay: patient is a 74 YO female a past medical history of hypertension, hyperlipidemia, who presented to the emergency department with acute onset of nausea, vomiting, and RUQ abdominal pain shortly after meal.  On arrival, the patient was hemodynamically stable but she was found to have elevated LFTs with cholestatic pattern as well as potassium 2.6.  CT abdomen and pelvis was obtained which showed gallbladder and cystic duct distention, mild intrahepatic and extrahepatic biliary dilatation, radiographic findings suggestive of choledocholithiasis.  Gastroenterology was consulted who recommended ERCP.  Potassium was replaced.  The patient initially underwent EGD given limited anesthesia availability, which was negative for Zenker's diverticulum, but did show esophageal mucosa consistent with short-segment Barrett's esophagus as well as a large hiatal hernia, otherwise unrevealing.  Patient then underwent ERCP on 3/17/2023 with Dr., where biliary sphincterotomy was performed, the common bile duct was dilated, the biliary tree was swept, and choledocholithiasis was visualized and removed.  Patient tolerated the procedure well.  General surgery was consulted for cholecystectomy evaluation given her presentation.  She underwent robotic assisted laparoscopic cholecystectomy on 3/18/2023 with another Dr. which she tolerated without immediate complicatinon.  In the interim, she was receiving maintenance IV fluids.  She initially tolerated the surgery well.     However, postoperatively on 3/18, she began exhibiting acute encephalopathy and respiratory distress, becoming acutely hypoxic.  Attempt was made to place her on BiPAP, however she acutely developed nausea and vomiting.  Given her respiratory distress and aspiration risk, ICU was consulted and the patient was intubated for airway protection.  The patient was diuresed and started on antibiotics given concern for aspiration pneumonia.  She would improvement in her oxygen requirements and was able to be extubated on 3/19 without postextubation complication.  She was transferred to floor status.     Antibiotics were discontinued given low suspicion for aspiration pneumonia.  Suspect that her acute respiratory decompensation was due to volume overload in setting of perioperative IV fluids and is supported chest imaging and physical exam.  Echo was obtained which showed EF 50% and mild aortic stenosis and mild-moderate MR. Diuresis was continued, after which the patient demonstrated improvement in her oxygen requirements and respiratory effort, being able to wean down to room air this admission.  She had resolution of her abdominal pain in her liver function testing had normalized, she otherwise remained hemodynamically stable.  Patient will be discharged home with PRN Lasix to treat volume overload with close PCP follow-up.  Patient will follow-up with General surgery.  She was discharged home in good condition."
This is referring to my first covid shot, my second dose is Friday, and I?ve had Covid in January.  Fought the usual side symptoms then. No post side effects until the first shot. I am taking allergy medicine, pill and nasal spray.  I didn?t lose my taste but things started to smell and taste so awful that I almost threw up on multiple occasions (Parosmia?). I?m not the easily queasy.  Things are almost back to normal with taste and  small working better. Caffeine and water most days. I also have G6PD if that matters.
Patient received first dose of Pfizer/BionTech vaccine ~2:40p Patient experiencing palpitations and dizziness.  patient took 1 nitro tablet,  3 minutes later patient told staff he was having chest pain and and nausea.  He stated nitro was helping but he knew this was gonna be a bad one and 911 was called .  2 minutes later(2:56p)  took 1 nitro tablet.  still having chest pain, dizziness nausea.  took third nitro tablet at 3:01p.  BP 125/101 and 86 BPM.   5 minutes later BP was 138/78 mmHg.  A and O x 3. ambulance transported him to hospital for further evaluation
Hospitalization: 2/4/2023 - 2/7/2023 (3 days) Presentation to the ED: worsening respiratory status.  COVID + date: 2/4/23. Treatment: no treatment specific to COVID.  Discharge to: hospice - expired 2/7/23.  002A21A 2/25/2021 017B21A 3/30/2021
Patient states that symptoms started at bedtime and she became very light headed & confused with memory loss.  It continued into the next day and was worse in the morning.  She was weak & is unsure that it didn't affect her vision.  She has no idea if she ate or drank anything all day because she just slept on & off and was generally incoherent.  She doesn't remember much about the entire day.  Previously on her second dose she had developed a severe headache but did not have a headache with this dose.  Her main complaints are the memory loss, weakness in limbs, light headedness & feeling like her mind was "in a fog".  By evening, she was a little better.
Patient received the covid vaccine on 12/21/2020.   c/o new onset of chills (temp 96-98.0), HA, nausea (no vomiting), and fatigue few hours after vaccination. Symptoms improved the next day.  On 12/28 she started to have HA, cough, SOB.  Denies fever. Cough relieved with an inhaler. She continues to use it every 2 hours for relief.  Last covid test was negative on 12/16/2020
Information has been received from a licensed practical nurse concerning a female who on 08-MAY-2008 was vaccinated with one dose of ROTATEQ (lot# 659915/0015X). The nurse reported that the 39 month old sister of the patient who was vaccinated developed rotavirus gastroenteritis from her sister. The patient developed vomiting and diarrhea for 48 hours. On 12-MAY-2008 she became dehydrated and was hospitalized. The outcome was unknown. There was no product quality complaint. No other information was provided. Additional information has been requested.
24 hours after vaccine, started having hard chills to the point that was unable to stand up.  Temperature rose to 101.2 F. Severe headache, queasy, eye pain
This initial spontaneous report was received from a physician referring to a 4 month-old male infant. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On 15-SEP-2015 at 10:45 hours, the patient was vaccinated with a dose of improperly stored ROTATEQ oral solution (lot # K023157 with expiration date 23-JUL-2016, second dose; dose was not reported), that was exposed to out of normal storage temperature range. No adverse event was reported. Lab diagnostics test were not performed. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received.
PATIENT VACCINATED AT TIME MENTIONED IN SECTION 4. HE WAS VACCINATED WITH 1mL OF VACCINE INSTEAD OF THE PRESCRIBED 0.5mL. PATIENT WOKE UP AT 0300 AM WITH A RASH AND WAS ITCHY. THE PATIENT EXPERIENCED TWO SYNCOPAL EPISODES WITHIN 15 MINUTES IN HIS LIVING QUARTERS. THE PATIENT'S TORSO FRONT AND BACK WAS COVERED IN A RED RASH. THE PATIENT WAS BROUGHT TO CLINIC FOR CARE.
Red swollen knot the size of a golf ball at injection site.  Itches and hurts.  No fever.
dose administered after expiration date; This case was reported by a other health professional via sales rep and described the occurrence of expired vaccine used in a male patient who received Men B NVS (Bexsero) (batch number unknown, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd August 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 3rd August 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 03-AUG-2022 Reporter's comment: The Healthcare Professional (HCP) reported that a patient had received Bexsero dose, which was already expired on 31st July 2022. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Bexsero, which led to expired vaccine used.
This spontaneous case reported by a physician (subsequently medically confirmed), describes the occurrence of SARS-CoV-2 positive test (positive for COVID-19), cough, hypogeusia (decreased taste and smell) and anosmia (decreased taste and smell) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011J20A) for COVID-19 immunization. Concurrent medical conditions included asthma since Jun 5, 1960. On Dec 23, 2020, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 23, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. In December 2020, patient experienced cough, hypogeusia (decreased taste and smell) and anosmia (decreased taste and smell). On Dec 26, 2020, patient had a SARS-COV-2 positive test (positive for COVID-19). The patient treated with prednisone on Dec 27, 2020 for COVID-19, at a dose of 40 milligram once a day and Regeneron monoclonal antibodies, on Dec 27, 2020, for COVID-19, at an unspecified dose and frequency. On Dec 27, 2020, SARS-CoV-2 positive test (positive for COVID-19), cough, hypogeusia (decreased taste and smell) and anosmia (decreased taste and smell) resolved. Diagnostic results: On Dec 26, 2020; SARS-CoV-2 test: Positive. The reporter did not provide any causality assessments. Patient reported he experienced fever, rigors and severe fatigue after receiving Regeneron monoclonal antibodies but is feeling better now. Most recent follow-up information incorporated above includes: On Apr 17, 2021: Follow up information received on Apr 17, 2021. Added event stop date Dec 27, 2021 and updated outcome of the event as recovered/resolved. Patient details and medical history added. Action taken updated. Sender's comments: Based on the available  information the events mentioned unlikely related to mRNA-1273.
Child had fevers at home and one episode of rash on chest that resolved;  On Oct 15th, child died at home.
local reaction lt upper arm @ site of inj;gen rash reaction;reaction occurred before pt left office;DPH administered;
Vaccine received Thursday.  Early Monday morning I started itching, in all my joints.  This then spread over my whole body, which turned blotchy and red.  I applied hydrocortisone cream and took took benadryl on Monday afternoon.  The problem resolved itself by the following morning.
covid vaccine breakthrough case  all Moderna dose 1 2/9/21  038K20A dose 2 3/9/212 030A21A dose 3 12/3/21 012H21B
Pt recvd vax w/an expired lot of measles vax on 3MAY91; pt exp sl pain @ inject site;
This spontaneous report as received from a nurse referring a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history, any known allergies or reactions or concomitant medications. On 19-APR-2017, the patient was vaccinated inadvertently with a dose of expired of M-M-R II lot # L000458 with an expiration date of 06-JAN-2017, for prophylaxis (dose and route of administration). No adverse effect reported. No product quality complaint was involved. No further information was provided. Additional information has been requested.
On 8/15/14 one of our clinical nurses noted an extra MENVEO diluent in the box. 4 doses of this vaccine had been given 8/14/14 by 3 different nurses. On 8/15 the times the vaccine was given were researched to know which 4 may have received the powder only. This client was one of the 4. No nurse working could be 100% sure that they gave the vaccine correctly (possibly using a sterile diluent) all 4 clients were notified by the supervisor who recommended revaccination. Plant to band vaccines and diluent has been implemented and double checking before giving the vaccine.
After 2 -4 hours I began feeling that my heart was racing. It would come and go.  I decided to go to an urgent care. Was given an EKG and it was normal. Was advised to take a Benadryl and  rest. And If condition continued, to report to an ER.  Felt better after taking meds. Next day 12/30 began feeling flu like symptoms (achy and lethargic) . Today 12/31, feel slightly better, but injection site is very painful. I have never had a reaction to a vaccine before and I am not allergic to any meds to my knowledge.
SMALL RED BUMPS LOOKED LIKE A SPIDER BITE. By next day rash had spread from hip to buttocks and belt line of waist. By day six strong pain developed in groin area near leg.  Went back to doctor and he prescribed nortriptyline and valacyclovir.
The RN was giving a patient the flu vaccine in the physician's office. She attached the needle, held the syringe/needle upright, and expressed out all of the air. After preparing the patient's arm (specifically, the deltoid muscle), she inserted the needle and attempted to aspirate. Seeing no aspirate, she proceeded to depress the plunger to give the vaccine. At this point, the glass flange nearest to the plunger shattered. The nurse reports she met no resistance and there were no indications prior to the event that the device was faulty (e.g.: no cracks in the glass). The patient did not move, squirm, or tense the muscle during the injection. The patient was not harmed; however, the nurse's finger was cut in the process. There was no glass in the nurse's finger -- only a small cut which was cleaned and a bandaid was applied. No further medical intervention was required for the nurse. Staff obtained another vaccine and administered it to the patient without difficulty. There was no delay or interruption in the patient's care. Of note, the vaccine is stored in a monitored refrigerator. The temperature in the refrigerator remains constant and the vaccine has not been subject to heat or freezing temperatures. The staff giving the vaccine are medically trained to perform this procedure and have done so many times--they are very experienced in giving injections. Staff do not know why this occurred.
arm pain; hurts to move her arm; coudn't even see; total discomfort; trembling eyes; insomnia; sensation of fire in her head; Nausea; terrible headache that stops when she rests; Numbness in pinky finger; A spontaneous report was received from a consumer who was a female patient who received Modern's COVID-19 vaccine (mRNA-1273) and experienced total discomfort, trembling eyes, couldn't even see, insomnia, sensation of fire in her head, arm pain, nausea, terrible headache that stops when she rests, numbness in pinky finger and it hurts to move her arm.  No past medical history was reported.   Concomitant medication use was not reported.   On 02-FEb-2021, prior to the onset of the events, the patient received the first dose of mRNA-1273 (Lot unknown)  intramuscularly for prophylaxis of COVID-19 infection. On 24-Feb-2021, the patient called to report that she had tons of reactions including: total discomfort, trembling eyes, she couldn't even see, insomnia, a sensation of fire in her head, arm pain, nausea, a terrible headache that stopped when she rested, numbness in pinky finger and it hurt to move her arm.  No Laboratory details provided.  Treatment information was not provided.  . Action taken with mRNA-1273 in response to the events was not reported.   The outcomes of the events, total discomfort, trembling eyes, couldn't even see, insomnia, sensation of fire in her head, arm pain, nausea, terrible headache that stops when she rests, numbness in pinky finger and it hurts to move her arm, were considered unknown.  .; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
A 64 year old female pt experienced nausea, malaise, neurological problems including slurred speech, slow thinking, trouble driving, inability to integrate traffic signals, feeling like she was drunk, and sleepiness at work. She also experienced vomiting, diarrhea, weakness, not being able to eat, and itching in the abdominal area, after being treated with RabAvert for post exposure prophylaxis after being bitten by a raccoon. She received five injections of RabAvert from June03 to Jul03, with the last one given 4 to 10 days late. The pt's medical history was significant for acute pancreatitis on approx 14Dec03, for which she was hospitalized for 4.5 days, and a history of triglycerides 17 times the normal range. Concomitant medications included Gemfibrozil. On 20Jun03, approx 2 days after the first injection of RabAvert, the pt experienced nausea, malaise, neurological problems including slurred speech, trouble driving, inability to integrate traffic signals, feeling like she was drunk, slow thinking and sleepiness at work. She also experienced vomiting, diarrhea, weakness and not being able to eat. In mid-July she experienced itching in the abdominal area. The symptoms lasted through mid Oct2003. The pt reported feeling better after that but still tired. Follow up received on 13Aug04: the pt was bitten by a young raccoon on 13Jun03. The dates of the RabAvert injections were provided. All of the reported events had resolved except for the high triglyceride levels that continued to be 17 times the normal. Follow up information received on 18Aug04: the pt was placed on seven days of Ciprofloxacin in May04 for post surgery prophylaxis. The RabAvert injections were on 17Jun03, 20Jun03, 24Jun03, 02Jul03 and 18Jul03. The triglyceride level increased from 2200 mg/dl on 17Jul04 to 3,518 mg/dl on 24Jul04 and remained elevated. The reporter thinks that the high triglyceride level is related to the RabAvert injections because all of her triglyceride results prior to the RabAvert injections were normal. No triglyceride testing was done after the RabAvert injections until June 2004. The results were reported in July04. Follow up information received on 20Sep04: Although the pt was hospitalized for 4.5 days for acute pancreatitis, the pt had a history of pancreatitis and this was considered a flare-up of her pre-existing condition. Her triglycerides returned to normal and all other symptoms resolved.
Severe vertigo when laying down. Not able to turn head while in prone position without severe vertigo. Sunday, Monday and Tuesday (each day 3, 4 and 5) after injection, progressively worse. Wednesday evening used Zyrtec-D as suggested from website. Only using OTC medicine; improving.
Woke up 10 hours later with severe arm pain, chills, sweating, shivering, over all muscle pain, body pain, hands shaking badly. Continued for the next 10 hours before slowly subsiding.    I had itching at the first injection site four weeks prior.
Information has been received from a licensed practical nurse concerning a 12 month old  who on 01/09/02 was vaccinated SC in the right arm with a first dose of Varivax. Concomitant vaccines included a first dose SC in the left arm of MMRII. On 01/15/1002, the patient  developed a varicella-like rash on his face which spread all over his body. The nurse reported that the patient was afebrile on 01/15/02. On 01/16/02, the patient presented with pinhead red papules vesicles an scrabed lesions. The patient was treated with diphenhydramine  (Benadryl), elixir and calamine/camphor/pramoxine hydrochloride (Aveeno) Bath. Additional information has been requested.
Pfizer Dose 1 9/25/21 (lot NA) Pfizer Dose 2 11/13/21 (lot NA) COVID Positive 1/18/22  1/18/22: The patient complaining from generalized weakness associated with shortness of breath with minimal exertion associated with dry cough and episodes of postural dizziness, no fever or chills or sore throat, no chest pain or palpitation or lower limb swelling.  She is vaccinated for COVID-19 and she did not get the booster.   She is a former smoker and currently vaping.  She is morbidly wheeze and she does not use CPAP at home and no official diagnosis of obstructive sleep apnea.   At emergency she was hypoxic requiring 12 L of oxygen   ABG show severe mixed respiratory and metabolic acidosis which improved after IV fluids, her labs show leukopenia  CT chest reviewed personally and show bilateral ground-glass opacity with focal consolidation  1/20/22: The patient known to be morbidly obese, vaccinated for COVID-19, presented with fever and chills and shortness of breath with cough and chest discomfort with nausea, she was hypoxic and require initially BiPAP, had bilateral wheezing and crepitation her chest exam with decreased air entry, her ABG show metabolic and respiratory acidosis, had chest CT angiogram negative for PE and show bilateral ground-glass opacity with focal linear consolidation, patient started on remdesivir and dexamethasone and antibiotics with CPAP hs with improvement in her respiratory status until she does not require oxygenation at rest.  Oxygen walking test completed and show the patient does not require oxygenation at rest and she require 3 L of oxygen while ambulating.  The patient will need to continue her medication, follow-up as an outpatient to schedule a sleep study follow-up with pulmonologist.  Counseled about losing weight and avoid vaping/smoking.
Oct 1st and 2nd weeks I felt burning sensation while passing urine. Oct-16 I saw blood in my urine. Went to pharmacy clinic and got uti tested which was negative. Nurse prescribed bactrim tablets for 4dats which I took. Later primary care doctor ordered abdomen and pelvis ultrasound which was negative.  Later saw urologist and they ordered CT scan and cystoscope which were negative. Blood test showed creatinine 1.5 and gfr 59. Urine analysis showed 1+ protein. Later nov-10 saw nephrologist and got all autoimmune blood tests which came negative and in this day blood in urine , protein in urine , gfr and creatinine-blood tests all came back good and back to normal. Nephrologist didn?t want to go for renal biopsy since all results look good. My Blood Pressure and glucose levels were always good.
patient complains of shoulder swelling, chest pain and dizziness within 2 days of receiving vaccine
no adverse reaction as of this time. wrong dilution of vaccine (1.3 ml vs. 1.8 ml) monitor only, no treatment . reported to health office
Temp of 103.6 from Thursday til Sunday night, followed by hives (rash) Tuesday all over his body.
Pt had rash on back of shoulder+ described the injection site as "oozy" next day said looked Blistered around site told pt to call oncall MD since weekend. Went to urgent care told pt to use Bacitracin oint over weekend seems to be healing 9/18
Information has been received from a physician concerning a 20 or 21 year old female patient who in approximately April 2011, "about a month ago", was vaccinated with the first dose of GARDASIL, subcutaneously (lot number not reported). In approximately April 2011, "about a month ago", the patient developed syncope. No treatment was given for the adverse event. The patient did not seek medical attention. The patient recovered within a few seconds and was still continuing with treatment. No further information is available.